Webinar: FDA Annual Reporting Period for Drug Products

September 29, 2017 Daniel Henrich

In this webinar, you'll get an overview of the FDA's requirements for submissions during the annual reporting period to the electronic Drug Registration and Listing (eDRL) system. That includes drug product site Establishment Registrations and a brand new submission type, the Blanket No Change Certification for drug product listings.

Presenters John Lorenc and Jon Nolan will address the following:

  • High Level eRDL Requirements and History Overview
  • FDA Final Rule on eDRL (2016)
  • NEW No Change Certification Requirements for Drug Products (affects most drug product labelers and CMOs)
  • Establishment Registration Requirements Review
  • Consequences of Non-Compliance
  • Q&A from the Audience

Remember, the annual reporting period runs from October 1 to December 31 of each year. Don't miss it!

Previous Article
Webinar: UDI and the EU MDR: What You Need to Know
Webinar: UDI and the EU MDR: What You Need to Know

Reed Tech Life Sciences and PRISYM ID team members discuss Unique Device Identification in the EU.

Next Video
NHS eProcurement Q&A
NHS eProcurement Q&A

Gary Saner and John Lorenc respond to questions submitted during a recent webinar on NHS eProcurement. Su...

Need additional information?

Contact Us